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Hgt1p, a member of the oligopeptide transporter family, is a
high affinity glutathione transporter from the yeast Saccharo-
myces cerevisiae. We have explored the role of polar or charged
residues in the putative transmembrane domains of Hgt1p to
obtain insights into the structural features of Hgt1p that govern
its substrate specificity. A total of 22 charged and polar residues
in the predicted transmembrane domains and other conserved
regionswere subjected to alaninemutagenesis. Functional char-
acterization of these 22 mutants identified 11 mutants which
exhibited significant loss in functional activity. All 11 mutants
except T114A had protein expression levels comparable with
wild type, and all except E744A were proficient in trafficking to
the cell surface. Kinetic analyses revealed differential contribu-
tions toward the functional activity of Hgt1p by these residues
and identified Asn-124 in transmembrane domain 1 (TMD1),
Gln-222 in TMD4, Gln-526 in TMD9, and Glu-544, Arg-554,
and Lys-562 in the intracellular loop region 537–568 containing
the highly conserved proline-rich motif to be essential for the
transport activity of the protein. Furthermore, mutants Q222A
and Q526A exhibited a nearly 4- and 8-fold increase in the Km
for glutathione. Interestingly, although Gln-222 is widely con-
served among other functionally characterized oligopeptide
transporter family members including those having a different
substrate specificity, Gln-526 is present only in Hgt1p and Pgt1,
the only two known high affinity glutathione transporters.
These results provide the first insights into the substrate recog-
nition residues of a high affinity glutathione transporter and on
residues/helices involved in substrate translocation in the struc-
turally uncharacterized oligopeptide transporter family.
Hgt1p or ScOpt1p, a polytopic membrane protein, from the
yeast Saccharomyces cerevisiae, was the first high affinity gluta-
thione transporter to be identified in any system (1). Hgt1p
belongs to a relatively novel family of transporters, the oli-
gopeptide transporter (OPT)3 family, that contains a large
number of fungal, plant, and prokaryotic members (2). The
functional characterizations of a few of the fungal and plants
members have demonstrated their ability to transport oli-
gopeptides, glutathione, and metal-secondary amino acid con-
jugates by harnessing the proton gradient across the plasma
membrane (3–7). Furthermore, these studies have also high-
lighted the physiological significance of this family in assimila-
tion/mobilization of oligopeptides as nutrients in fungi and
plants and in maintenance of metal homeostasis in plants.
However, the majority of the members are yet uncharacterized
and need to be definedwith respect to their substrate specificity
and physiological role.
A complete lack of information on the structural features of
the OPT family further limits our understanding of this large,
uncharacterized family. Identification of residues or motifs
critical for substrate recognition among the functionally char-
acterizedmembers would enable functional characterization of
the new members within the family. This has prompted us to
initiate a systematic study on the structure-function character-
ization ofHgt1p as a representative of theOPT family. Not only
is Hgt1p the best characterized member of the OPT family in
terms of its substrate specificity, being also able to transport
some oligopeptides albeit with low affinity (1, 7, 8), its native
host S. cerevisiae is a well established model system and easily
amendable for mutagenesis-based structure-function studies.
We have recently investigated the role of the 12 native cysteine
residues in the structural stability and the transporter activity of
the protein where 2 of the cysteines were found to be essential
for functionality (9). However, no hints on the importantmotifs
or conserved amino acids of Hgt1p (or any othermember of the
OPT family) that could be involved in substrate recognition
have been obtained so far. In the current study we have focused
on the polar and charged residues in the transmembrane
domains of Hgt1p to explore their role in substrate recognition.
Glutathione, the substrate for Hgt1p, is a hydrophilic sub-
strate. Prior studies on structural characterization of transport-
ers of the other hydrophilic substrates using biochemical and
genetic strategies, such as site-directed mutagenesis and ran-
dom mutagenesis, have established the role of polar and
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charged residues in the transmembrane domains of transport-
ers in recognition, binding, and translocation of substrates (10–
18). The availability of the crystal structures of a few transporter
proteins have further enabled direct visualization of such inter-
actions between the key residues in the transmembrane
domains and the substrate molecule (19–22). In light of these
studies we anticipated that few of the charged or polar residues
in the predicted transmembrane domains of Hgt1p would be
involved in substrate recognition and translocation across the
membrane. Hence, a total of 22 polar or charged amino acids
spanning the predicted transmembrane domains ofHgt1pwere
subjected to alanine scanning and functionally characterized.
Detailed biochemical characterizations of these mutants re-
vealed that Asn-124, Gln-222, Gln-526, Glu-544, Arg-554, and
Lys-562 are key residues for the transport activity of Hgt1p. As
replacement of Gln-222 in TMD4 and Gln-526 in TMD9 with
alanine resulted in a significant decrease in the affinity of the
transporter for glutathione, it suggested that the two residues
might directly participate in glutathione recognition as a sub-
strate. These observations provide the first insights into sub-
strate binding residues in Hgt1p, a member of a novel and
important transporter family (OPT family).
EXPERIMENTAL PROCEDURES
Chemicals and Reagents—All the chemicals used in this
study were obtained from commercial sources andwere of ana-
lytical grade. Media components, fine chemicals, and reagents
were purchased from Sigma Aldrich, HiMedia (Mumbai,
India),Merck, USBCorp., or Difco. Oligonucleotides were pur-
chased fromBiobasic Inc. (Markham,ON,Canada). Restriction
enzymes, Vent DNA polymerase, and TaqDNA polymerase
and other DNA-modifying enzymes were obtained from New
England Biolabs, (Beverly, MA). A DNA sequencing kit (ABI
PRISM 3130 XL with dye termination cycle sequencing ready
reaction kit) was obtained from PerkinElmer Life Sciences. Gel
extraction kits and plasmid miniprep columns were obtained
fromQiagen (Valencia, CA) or Sigma. [35S]GSH (specific activ-
ity 1000 Ci mmol1) was purchased from Bhabha Atomic
Research Centre, Mumbai, India. Hemagglutinin (HA)-tag
(6E2) mouse monoclonal antibody and horse anti-mouse
horseradish peroxidase-linked antibody were bought from Cell
Signaling (Danvers, MA). Alexa Fluor 488-conjugated goat
anti-mouse antibody was obtained from Molecular Probes
(Eugene, OR). Hybond ECL (nitrocellulose) membrane and
ECL plus Western blotting detection reagents were purchased
from Amersham Biosciences.
Strains, Media, and Growth Conditions—The Escherichia coli
strain DH5 was used as a cloning host. The S. cerevisiae strain
(ABC 817) bearing an HGT1 disruption in BY4741background
(MATa his31 leu20 met150 ura30 hgt1::LEU2) is defi-
cient in glutathione uptake ability and was used in the experi-
mental studies (1). The yeast strainwas regularlymaintained on
yeast extract, peptone, and dextrose medium and grown at
28–30 °C. The yeast transformants were selected and main-
tained on synthetic defined minimal medium containing yeast
nitrogen base, ammonium sulfate dextrose supplemented with
adenine, histidine, leucine, lysine, methionine, tryptophan, and
uracil at 50 mg/liter as per requirement. Growth, handling of
bacteria and yeast, and all the molecular techniques used in the
study were according to standard protocols (23, 24).
Site-directed Mutagenesis and Plasmid Construction—The
double-tagged HGT1, tagged with hexahistidine epitope at the
N terminus and HA tag at the C terminus (9), was subcloned
downstream of the TEF promoter at BamHI and EcoRI site of a
modified p416TEF vector (p416M1-TEF) in which all the
restrictions sites flanking the BamHI and EcoRI restriction sites
have been removed by blunting and re-ligation.
The resulting plasmid pTEFM1-His-HGT1-HA was used as
a template to introduce two silent mutations to generate the
restriction sites-MscI (1366) and XbaI (1584) in the wild-type
HGT1 gene using the QuikChange site-directed mutagenesis
kit with respective mutagenic oligonucleotides pairs given in
supplemental Table 1. This modification generated a recombi-
nant HGT1 gene that was unaltered in the encoded protein
product but had additional restriction sites to facilitate cloning
and screening of mutant DNA (Fig. 1). This modified gene
product was used as a template for site-directed mutagenesis
for creation of different site-directed mutants of Hgt1p using
either the QuikChange site-directed mutagenesis kit or the
splice overlap extension strategy. The different mutagenic oli-
gonucleotides pairs used for generation of these mutants are
given in supplemental Table 1.
For using the QuikChange site-directed mutagenesis kit
to generate the mutants, the double-tagged HGT1 (N-His-
HGT1-HA) was subcloned into pBSK vector and used as a
template together with different mutant primer pairs (supple-
mental Table 1) in mutagenic PCR set up as per the manufac-
turer’s instructions. The resulting mutants were sequenced to
confirm the presence of the desired nucleotides changes and
rule out any undesired mutations introduced during the muta-
genic procedure. The fragments containing themutations were
subcloned back into theTEF vector background (pTEFM1-His-
HGT1m-HA) using the appropriate restriction sites for subse-
quent analyses. While using the splice overlap extension strat-
egy, the mutations were directly generated in the TEF vector
background, and the resulting mutations were confirmed by
sequencing the appropriate regions.
The Plate “Dual Complementation-cum-toxicity” Assay—
The development of the assay and procedure has been de-
scribed previously (9). Briefly, the yeast strain met15hgt1
(ABC817)was transformedwith a single copy, centromere vec-
tor expressing wild type, or differentHGT1mutants expressed
downstream of the TEF promoter. Transformants were grown
in minimal media containing methionine and other supple-
ments without uracil overnight. These cultures were reinocu-
lated in the same media and allowed to grow till they reached
exponential phase. Equal numbers of cells were harvested,
washed with water, and resuspended in sterile water to an A600
of 0.2. These were serially diluted 1:10, 1:100, and 1:1000. 10 l
of these cell resuspensions were spotted on minimal medium
containing different concentrations of glutathione (15, 30, 50,
100, 150, 200 M) or methionine (200 M) as the sole organic
sulfur source. The plates were incubated at 30 °C for 2–3 days,
and photographs were taken. Only the data obtained with 15,
50, and 200 M GSH have been shown.
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Glutathione Transport Assay—met15hgt1 (ABC 817)
strain transformed with different plasmid constructs bearing
wild type or HGT1 mutants under the TEF promoter were
grown inminimalmedia containingmethionine and other sup-
plements without uracil overnight. These cultures were reinoc-
ulated in the same media and allowed to grow till they reached
exponential phase. Cells were harvested andwashed and put on
ice in aMES-bufferedmediumuntil the transport was initiated.
Transport experiments were carried out with [35S]GSH as
described earlier (1). The results were expressed as nmol of
glutathionemgprotein1min1. For the measurements of
total protein, 100 l of the above cell suspension (cell suspen-
sion volume used for the transport assay) was boiled with 15%
sodiumhydroxide for 10min followed by neutralization of total
cell lysate by the addition of hydrochloric acid. 100 l of this
crude cell lysate was incubated with 0.1% Triton X-100 for 10
min, and total protein was estimated by using the Bradford
reagent (Sigma) using bovine serum albumin as a standard.
Preparation of Cell Extract and Immunoblot Analysis—Total
crude cell preparation and immunoblot analysis was done as
described previously (25). Densitometry analysis of the unsat-
urated band signals was performed using the Scion Image soft-
ware to quantify the protein expression levels in different
mutants. The resulting signal intensity was normalized with
respect to the band surface area (in
square pixels) and expressed in arbi-
trary units. The relative protein
expression levels in the mutant
Hgt1p were represented as percent-
age expression relative to wild-type
Hgt1p.
Cellular Localization of the Mu-
tants by Confocal Microscopy—To
localize Hgt1p and its different ala-
nine mutants, indirect immunoflu-
orescence was performed using a
published protocol (26). Images
were obtained with an inverted
LSM510META laser scanning con-
focal microscope (Carl Zeiss) fitted
with a Plan-Apochromat 100
(numerical aperture, 1.4) oil immer-
sion objective. The 488-nm line of
an argon ion laser was directed over
an HFT UV/488 beam splitter, and
fluorescence was detected using an
NFT 490 beam splitter in combina-
tion with a BP 505–530 band pass
filter. Images obtained were pro-
cessed usingAdobe PhotoshopVer-
sion 5.5.
Sequence Analysis—The HGT1
open reading frame and Hgt1p
sequences were retrieved from the
Saccharomyces genome data base.
Themultiple sequence alignment of
the protein sequences was gener-
ated using ClustalX program using
default parameters (27). For the prediction of transmembrane
domains in Hgt1p, five different transmembrane prediction
software programs were used: HMMTOP (28), TMHMM (29),
MEMSAT (30), PHDHTM (31), and TopPRED II (32). The
Hgt1p amino acid sequencewas submitted as a query sequence,
and predictions were made in default settings.
RESULTS
Selection of Amino Acid Residues in TMDs of Hgt1p for Ala-
nine Scanning—A reasonably reliable topology model is a pre-
requisite for probing the role of amino acids in the transmem-
brane domains of Hgt1p. Previously, Becker and co-workers
(33) predicted a topology model of Hgt1p with 12 transmem-
brane domains and extracellular N and C termini using topol-
ogy prediction software in combinationwithmultiple sequence
alignment of the functionally characterized members of the
OPT family (Fig. 1). Although the software predicted 14 trans-
membrane domains, the authors had omitted two of the pre-
dicted domains corresponding to the regions 537–568 and
707–724 citing the presence of conserved proline-rich motifs
EXIXGYX2PG(R/K)PXAX4KX2G and PPX(N/T)P, respec-
tively, in these regions. These motifs consist of proline residues
in proximity to each other or a glycine residue, which theoret-
ically disfavors a helix formation and, hence, were predicted to
FIGURE 1. Pictorial representation of putative Hgt1p topology showing the location of the charged/
polar residues subjected to alanine scanning in the study (A) and restriction sites (B) in HGT1. A, the
topology model is based upon consensus generated using six different topology predicting software pro-
grams by Becker and co-workers (33) previously. The 12 transmembrane domains are shown as rectangular
bars, and the residues subjected to alanine scanning in the study aremarked as circleswith residue identity and
number inscribed in them. The residues are shaded to reflect the effect of alanine substitution on transport
activity of Hgt1p (Table 2); residues shaded dark gray with white letters represent severe effect on transport
activity (Group I), residues shaded dark gray with black letters represent moderate effect on the activity (Group
II residues), residues shaded light gray with black letters represent mild effect on transport activity (Group III),
and residues shadedwhitewith black letters represent no tominor effect on the activity (Group IV). B, restriction
sites used for genetic manipulation in construction of different clones in the study aremarked by arrows, with
the transmembrane domains depicted as rectangular boxes with numbers. The asterisk marks the restrictions
sites introduced in HGT1 gene as silent mutations.
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form loops in the predicted topology model (33). We have car-
ried out an independent topology prediction analysis using also
additional membrane protein topology prediction software
reported in the literature. Our analysis leads us to concur with
the Becker topology model of Hgt1p with the 12 transmem-
brane domains (data not shown).Hence, the predicted topology
model has been used as a platform for the structure-functional
analysis of Hgt1p. However, in the absence of any firm experi-
mental evidence for excluding the two likely transmembrane
domains spanning the regions 537–568 and 707–724 in Hgt1p,
we have included these regions for our mutational study, while
staying with the Wiles et al. (33) topology model of Hgt1p.
In the absence of any previous hints on the important motifs
or conserved amino acids in the transmembrane domains of
Hgt1p (or any other member of the OPT family) that could be
involved in substrate recognition, we adopted a comprehensive
approach to identify the important residues or domains in
Hgt1p that may play a specific role in substrate translocation.
Glutathione, the substrate for Hgt1p, is a hydrophilic substrate,
and prior studies on structural characterization of transporters
of the other hydrophilic substrates have established that trans-
membrane domains lining the channels are rich in charged and
polar residues. An examination of the 12 predicted transmem-
brane domains of Hgt1p revealed that each of these domains
had at least one charged/polar residue in it, resulting in a total of
49 residues (Table 1). As the charged and polar residues that
form a part of the permeability channel show a characteristic
distribution where they often tend to cluster on one face of the
helix (amphiphatic arrangement), helix wheel projections were
drawn for each of the 12 transmembrane domains (supplemen-
tal Fig. 1). These helix wheel projections were analyzed for the
presence and distribution of the charged and polar residues in
these domains (supplemental Fig 1 and Table 1). Two of the 12
transmembrane domains (TMD 5 and TMD11) contained only
a single polar residue, and hence, were not included in this
study. TMD8 contains three polar residues, Gln-489, Cys-501,
and Cys-502. However, the two cysteine residues in TMD8 are
not crucial for the functional activity of Hgt1p (9), and hence,
the TMD8 was also not included in our mutational analysis of
Hgt1p. Of the remaining 9 transmembrane domains, TMDs 1,
2, 4, 6, 7, 9, 10, and 12 have a clear distinction between the polar
and nonpolar phase, and TMD3 is very rich in polar residues,
which are scattered all around the helix. Hence, from these nine
transmembrane domains, all the five charged residues in the
predicted transmembrane domains (Glu-135, Arg-150, His-
445, Glu-612, and Glu-744) were selected for mutational anal-
ysis in this study. With the remaining polar residues in the
transmembrane domains, the following two criteria were used
to select the residues; (a) restriction was made with respect to
number of residues, selecting one or. at the most. two residues
from each transmembrane domains so as to cover all the remain-
ing nine transmembrane domains inHgt1p, and (b) when picking
more thanonepolar residue ina transmembranedomain, residues
present in different faces of the helices were selected.
Inaddition, threeof thehighlyconservedchargedresidues,Glu-
544,Arg-554, andLys-562,wereselected fromtheregionspanning
537–568, and two polar residues (Asn-710 and Asn-722) were
selected from the region spanning 707–724. Thus a total of 22
aminoacids representativeof 9 transmembranedomainsofHgt1p
and 2 intracellular loops were mutagenized to the alanine residue
and evaluated for the functional activity (Fig. 1 and Table 1).
Functional Evaluation of the Alanine Mutants of Hgt1p—A
preliminary characterization of the alanine mutants of Hgt1p
was done using a plate-based dual complementation-cum-tox-
icity assay, previously designed for the rapid evaluation of the
functional activity of themutants of the transporter (9). Briefly,
the assay is based upon the dual behavior of Hgt1p, expressed
from TEF promoter in amet15hgt1 strain, an organic sulfur
auxotroph defective in glutathione uptake. While at low gluta-
thione concentrations (15Mor lower),HGT1 expressed under
the TEF promoter complements the growth defect in a
met15hgt1 strain very well (1), the same construct results in
toxicity when cells are grown in medium containing 30 M or
higher glutathione concentrations (34). Thus, the assay is used
to evaluate the functional activity of Hgt1p with respect to two
parameters. (a) ability to complement theGSH transport defect
of the strain met15hgt1 at low concentrations of GSH and
(b) the ability to cause toxicity in media containing higher con-
centrations of GSH.
The plasmids bearing wild-type Hgt1p or with the mutated
residue in Hgt1p were individually transformed into the
met15hgt1 strain (ABC817) and checked for growth by dilu-
tion spotting on minimal media containing a range of glutathi-
one concentrations as the sole source of organic sulfur (Fig. 2).
Functional evaluation of themutations inHgt1p using the plate
assay identified four subgroups, (a) severe effect (complemen-
TABLE 1
Polar/charged residues in the transmembrane domains of Hgt1p and residues selected for alanine scanning in this study
TMD Polar/charged residue present in the domain Residue mutated to alanine
TMD1 (109–127) Thr-109, Thr-113, Thr-114, Asn-124, Gln-125 Thr-114, Asn-124
TMD2 (134–155) Glu-135, Asn-137, Gln-142, Cys-145a, Arg-150 Glu-135, Asn-137, Arg-150
TMD3 (179–200) Thr-182, Thr-188, Ser-189, Ser-190, Thr-191, Asn-199 Thr-188, Ser-190
TMD4 (212–232) Gln-214, Thr-220, Ser-221, Gln-222, Thr-232 Gln-222
TMD5 (277–296) Ser-285
TMD6 (354–374) Ser-355, Asn-357, Thr-358, Ser-361, Cys-372a Ser-355, Asn-57
TMD7 (427–449) Ser-427, Ser-431, Asn-435, His-445, Cys-446a Asn-435, His-445
TMD8 (483–502) Gln-489, Cys-501a, Cys-502a
TMD9 (509–529) Ser-519, Asn-522, Gln-526 Gln-526
Loop (537–568) Asn-540, Thr-543, Glu-544, Cys-547, Arg-554, Asn-558, Lys-562 Glu-544, Arg-554, Lys-562
TMD10 (591–613) Gln-596, Thr-600, Ser-603, Asn-607, Gln-611, Glu-612 Ser-603, Asn-607, Glu-612
TMD11 (661–679) Gln-679
Loop (707–724) Thr-707, Asn-710, Ser-712, Ser-718, Cys-720a, Asn-722 Asn-710, Asn-722
TMD12 (739–759) Glu-744, Ser-750, Cys-757a, Gln-759 Glu-744
a The cysteine residues have been subjected to mutagenesis analysis in an independent study (9).
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tation-defective at 15 M GSH, no toxicity at higher GSH con-
centrations; those mutants showing significant loss in activity
as reflected by loss in ability to complement hgt1 defect at low
glutathione concentrations), (b) moderate effect (complemen-
tation-positive at 15 M GSH, no toxicity at higher GSH con-
centrations; mutants that permitted growth at higher glutathi-
one concentration, i.e. no toxicity is observed in the cells
transformedwith these set ofmutants), (c) mild effect (comple-
mentation-positive at 15 M GSH, mild toxicity at higher con-
centrations; mutants showing decreased toxicity, with growth
observed at glutathione concentrations higher then 100 M,
unlike the wild type Hgt1p, for which toxicity sets in at 30 M
glutathione), and (d) very mild to no effect (complementation-
positive at 15 M GSH and severe toxicity at higher concentra-
tions; mutants which behave very similar to the wild-type pro-
tein in terms of their ability to complement the met15hgt1
strain (ABC 817) or cause severe toxicity to the cells (Table 2)).
To corroborate these spotting assays with actual transport
data, we measured the initial rate of [35S]glutathione uptake in
the met15hgt1 strain (ABC 817) transformed with the ala-
nine mutants of Hgt1p (Table 2).
Interestingly, the quantitative infor-
mation generated from the bio-
chemical assay also defined four
groups of activity which correlated
closelywith the plate assay; (a) those
with severe effect showed 20%
that of the activity compared with
the wild-type protein, (b) those with
moderate effect fell into roughly
20–30% activity bracket, (c) those
with mild effect retained nearly 50%
activity, and (d) thosewith verymild
to no effect showed 75% activity.
The only exception in this grouping
was the N124A mutant, which
despite showing complementation
ability comparable with wild-type
Hgt1p, exhibited only 16% transport
activity; nonetheless, it was placed
in Group II based upon its behavior
in the plate based dual-complemen-
tation assay. Furthermore, as the
plate assay generated a reliable pic-
ture of the activity of the different
mutants, we did not determine the
[35S]glutathione uptake activity for
all the mutants that fell into the last
group.
Among the 22 amino acids ini-
tially selected, we were able to iden-
tify 11 residues in the different
transmembrane domains of Hgt1p,
which when replaced by a relatively
inert residue (alanine) resulted in a
significant decline in glutathione
uptake ability of the protein. Six of
these residues led to severe defect in
transport ability of Hgt1p, and these residues were located in
TMD4 (Gln-222), TMD9 (Gln-526), the intracellular loop
between TMD9 and TMD10 (Glu-544, Arg-554, Lys-562) and
TMD12 (Glu-744). In contrast, five of the residues located in
TMD1 (Thr-114, Asn-124), TMD2 (Asn-137), TMD6 (Asn-
357), and TMD7 (His-445) led to amoderate effect on the func-
tional efficiency of Hgt1p upon being mutated to alanine. To
define the role of these residues in the function of Hgt1p, we
undertook a detailed biochemical characterization of these 11
mutants.
Evaluation of the Protein Expression Levels of Alanine
Mutants of Hgt1p Reveals That Only T114A Shows a Significant
Reduction in Protein Levels—The decreased activity of the ala-
ninemutants of Hgt1p observed using whole cell-based growth
or transport assay can be attributed either to decreased expres-
sion levels of the protein, a defect in trafficking to the cell sur-
face, or loss in the functional activity of the protein per se. The
protein expression levels of the Hgt1p mutants were measured
by immunoblotting. Equal amounts of the crude protein
extracts prepared from the met15hgt1 strain (ABC 817)
FIGURE 2. Functional characterization of alanine mutants of the polar/charged residues in the putative
transmembranedomains ofHgt1p. Themet15hgt1 strain (ABC 817)was transformedwithwild-type (WT)
Hgt1p and thedifferent alaninemutants ofHgt1pexpressedunder the TEFpromoter alongwith control vector
(p416M1-TEF) and used for plate-based dual complementation-cum-toxicity assay by dilution spotting on
minimal media containing different concentration of glutathione as described under “Experimental Proce-
dures.” The functional analysis of the alaninemutants of polar residues is shown inA and B and, for the charged
residues, in C.
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transformed with the plasmids bearing the alanine mutants of
Hgt1p were loaded onto the SDS-PAGE gels, electroblotted to
themembrane, andprobedwith anti-HAmonoclonal antibody.
As shown in Fig. 3, an 85-kDa band corresponding to the wild-
type Hgt1p was visualized for all the mutants, although the
mutants showed variation in the expression levels. Densitome-
try analysis of unsaturated band signals revealed that in partic-
ular T114A mutant showed a drastic fall in protein expression
levels, suggesting that the residue might be crucial for protein
folding and stability (Fig. 3). However, for the other mutants,
the protein expression levels did not appear to be significantly
altered. The protein expression levels ranged between 50 and
90% relative to the wild-type protein levels, indicating that
these mutants did not significantly perturb the protein struc-
ture and stability, and the significant loss in glutathione uptake
ability of these mutants was not a consequence of decreased
protein stability and protein expression levels.
Analysis of Cell Surface Trafficking of Mutants with Loss in
Functional Activity Reveals E744A Is Defective in Trafficking—
Hgt1p is a plasma membrane-localized transporter, and local-
ization studies with Hgt1p expressed from its native promoter
as well as from the constitutive TEF promoter has revealed
exclusive plasmamembrane localization for the transporter (9).
As any mutation that affects trafficking could also explain the
loss in functional activity, we examined all 11 mutants
expressed from the TEF promoter for their subcellular localiza-
tion by indirect immunofluorescence using anti-HA mono-
clonal antibody. A very robust signal was observed at the cellu-
lar periphery for the cells transformed with wild-type Hgt1p as
well as for themajority of themutants (N124A,N137A,N357A,
H445A, Q222A, Q526A, E544A, R554A, K562A) (Fig. 4).
Among these, K562A also showed a small amount of intracel-
lular signal in addition to the cell surface signal in few of the
FIGURE 3.Quantification of the total protein expression levels of alanine
mutantsofHgt1p showing severeeffect onactivity (Group Imutants) (A)
andmoderate effect on activity (Group II) (B). The crude extracts prepared
from the met15hgt1 strain (ABC 817) transformed with plasmids bearing
the different alanine mutants of Hgt1p were prepared, and20 g of total
protein was resolved using 9% SDS-PAGE, electroblotted to a nitrocellulose
membrane. The blot was probed with mouse anti-HA (Cell Signaling) at
1:1000 dilution as primary antibody and goat anti-mouse IgG horseradish
peroxidase-conjugated antibody (Cell Signaling, at 1:2500 dilution) as sec-
ondary antibody. The signal was detected using ECL kit (Amersham Bio-
sciences). Molecular weight markers (SM0431, MBI Fermentas) were used to
estimate the protein molecular weight. The total protein was quantified by
densitometry analysis ofproteinbands. Thedata areexpressedaspercentage
protein expression normalized to thewild-type (WT) expression level and are
the mean of the protein expression levels obtained in three independent
experiments. A representative blot is shown in the inset. Equal loading of the
proteins (20g) in each well of the gel was visually monitored by Coomassie
staining of a duplicate gel and Ponceau S staining of the membrane after
transfer (data not shown).
TABLE 2
Grouping of the alanine mutants of Hgt1p based upon their
effect on the functional activity of the transporter using dual
complementation-cum-toxicity assay and percentage transport
activity
The mutants were analyzed for the functional activity using the plate-based assay
categorized into four groups based upon their activity in terms of their ability to
complement met15hgt1 strain (ABC 817) at low concentrations of glutathione
and cause toxicity to the cells at glutathione concentrations higher than 50 M. For
quantification of the functional activity of the mutants, the initial rate of uptake of
glutathione (100 M) was measured inmet15hgt1 strain (ABC 817) as described
under “Experimental Procedures.” The results were normalized to the rate of
glutathione uptake measured for the wild-type Hgt1p (54.5  4.3 nmol
min1mgprotein1). Data were obtained from two independent experiments done
in triplicate and are represented as percentage activity relative to wild-type Hgt1p
and expressed as the mean S.E. Visual scoring symbols:, yes;/, mild;, no.
ND, not determined.
Mutant (TMD) Complementation(15 M GSH)
Toxicity
(>50 M
GSH)
Transport
activity
(mean S.E.)
WT-Hgt1p   100.0 1.6
%
Severe effect-Group I
Q222A (TMD 4)   9.2 0.6
Q526A (TMD 9)   19.2 0.0
E544A (ICL9–10) /  20.8 0.1
R554A (ICL9–10) /  18.7 0.1
K562A (ICL9–10)   1.4 0.0
E744A (TMD 12)   6.2 0.0
Moderate effect-Group II
T114A (TMD 1)   26.5 0.1
N124A (TMD 1)   15.6 0.7
N137A (TMD 2)   22.7 0.5
N357A (TMD 6)   28.3 1.8
H445A (TMD 7)   25.7 1.5
Mild effect-Group III
E135A (TMD 2)  / 57.2 1.6
N435A (TMD 7)  / 47.6 1.9
S603A (TMD 10)  / 69.1 4.5
No to minor effect-Group IV
R150A (TMD 2)   ND
T188A (TMD 3)   89.8 6.2
S190A (TMD 3)   76.1 7.2
S355A (TMD 6)   ND
N607A (TMD 10)   ND
E612A (TMD 10)   89.4 3.2
N710A (ICL11–12)   ND
N722A (ICL11–12)   ND
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cells, suggesting a partial defect in trafficking of the mutant.
However, very poor cell surface signal was detected for T114A
and E744A mutant. The staining pattern for E744A suggested
that the protein was trapped in the endoplasmic reticulum.
These findings suggest that replacement of Glu-744 residues
with alanine interfered with the trafficking of the protein to the
cell surface, and this may be the principal reason for the
observed loss in functional activity of the mutant.
In the case of T114A a diffused and relatively weak cytosolic
signal was observed, which probably reflects the decreased pro-
tein expression levels observed earlier for this mutant in the
Western blot. These findings further confirm that loss in activ-
ity of the T114A mutant is mainly a consequence of decreased
protein expression levels.
Kinetic Analysis of theMutants Reveals a Critical Role of Asn-
124 (TMD1), Gln-222 (TMD4), and Gln-526 (TMD9) in Gluta-
thione Transport by Hgt1p—The analysis of total protein
expression levels and cell surface localization of the mutants in
Group I andGroup II revealed thatwith the exception ofT114A
and E744A, the remaining mutations did not bear a significant
effect on the protein expression or its cell surface localization.
This suggests that loss in functional activity of these mutants
might be because of some specific defect related to the ability of
the mutants to transport glutathione. Hence, to characterize
these residues for their role in substrate binding or translo-
cation, we undertook themeasurement of kinetic parameters of
themutants bymeasuring the initial rates of glutathione uptake
over a range of glutathione concentrations. As K562A and
E744A had very poor activity, these could not be included for
the kinetic study. The apparent Km and Vmax values and the
Km/Vmax ratios (transport efficiencies) obtained for the rest of
the mutants are summarized in Table 3. The Km and Vmax val-
ues for wild-type Hgt1p were estimated to be 48.1  10.5 M
and 57.8  3.9 nmol of glutathionemgprotein1min1.
Although the Km was in close agreement with the previously
reported value (53.8  5.5 M), the Vmax differed significantly
from the previously reported value (10.0  0.6 nmol of
FIGURE 4. Cell surface localization of alanine mutants of Hgt1p show-
ing a severe effect on activity (Group I mutants) and moderate effect
on activity (Group II). The strain met15hgt1 (ABC 817) was trans-
formed with plasmids bearing the different alanine mutants of Hgt1p and
labeled by indirect immunofluorescence using mouse anti-HA (Cell Sig-
naling) primary antibody (at 1:100 dilution) and goat anti-mouse IgG
horseradish peroxidase-conjugated antibody (Cell Signaling) secondary
antibody (at 1:500 dilution) and visualized using confocal microscope, as
described under “Experimental Procedures.” Only fluorescence images
have been shown. WT, wild type.
TABLE 3
Kinetic characterization of the mutant showing severe/moderate loss in activity; estimation of the kinetic parameters and normalization to
the protein expression levels
The initial rate of glutathione uptakewasmeasured at glutathione concentrations ranging from 0.0125 to 0.4mMby harvesting cells incubatedwith radiolabeled glutathione
at 30- and 180-s time intervals. After subtracting the initial rate of glutathione uptake in vector-transformed met15hgt1 strain (ABC 817) from the initial rate of
glutathione uptake in the different test construct-transformed yeast cells, initial rates of glutathione uptake corresponding to Hgt1p were calculated. The experiment was
repeated aminimumof two times for eachmutant in duplicate at each glutathione concentration. The averageKm andVmax values were determined by nonlinear regression
analysis of V versus 	S
 graphs showing saturation kinetics using GraphPad Prism Version 5.01 software. NM, not measurable.
Mutant (TMD) Protein expression Kinetic parameters Corrected Vmaxa Corrected Vmax/KmKm Vmaxa
% M nmol of glutathione·
mg·protein1min1
nmol of glutathione·
mg·protein1min1M1
WT-Hgt1p 100 48.1 10.5 57.8 3.9 1.2
Severe effect (complementation defective)
Q222A (TMD4) 91 213.9 69.5 11.4 1.9 12.5 0.1
Q526A (TMD9) 62 372.3 106.7 38.0 6.5 61.3 0.2
E544A (ICL9–10) 86 85.2 25.1 10.5 1.2 12.2 0.1
R554A (ICL9–10) 74 116.6 53.1 16.5 3.1 22.3 0.2
Moderate effect (no toxicity)
T114A (TMD1) 11 40.2 19.0 8.3 1.1 75.5 1.9
N124A (TMD1) 58 NM NM
N137A (TMD2) 51 29.3 17.0 21.7 3.3 42.5 1.5
N357A (TMD6) 59 24.3 11.6 19.6 2.3 33.2 1.4
H445A (TMD7) 67 28.5 11.1 23.6 2.4 35.2 1.2
a Vmax was adjusted to the protein expression levels.
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glutathionemgprotein1min1) (1). The difference in the
Vmax is likely to be a consequence of growing the yeast cells in
medium additionally supplemented with adenine, leucine,
tryptophan, and lysine (in addition to the required supplements
histidine and methionine). This medium leads to significantly
better growth that could have resulted in better protein expres-
sion. AsKm is an intrinsic property of the protein whereasVmax
can vary with the protein expression levels and experimental
conditions, the results were considered to be reliable and used
for evaluation of the mutants.
The kinetic characterization of the mutants revealed inter-
esting insights into the roles of residues in the functional activ-
ity of the transporters. In particular, the Q526A mutant in
TMD9 showed a nearly 8-fold increase in itsKm for glutathione,
with the corrected Vmax value nearly the same as the wild-type
Vmax value, thereby resulting in nearly a 7-fold decrease in the
transport capacity. A nearly 4-fold increase in Km for glutathi-
one was also observed for another glutamine residue, Gln-222,
in TMD4. However, Q222A also exhibited a significant loss in
corrected Vmax value such that the transport efficiency of the
mutant Hgt1p fell by nearly 20-fold. The significant decrease in
affinity for glutathione uponmutation of the Gln-222 and Gln-
526 to alanine suggests these residues play a critical role in
interacting with the substrate.
In contrast, the kinetic analysis of E544A andR544A revealed
that mutant yielded a nearly 2-fold increase in Km values but a
drastic loss in the catalytic activity. The corrected Vmax values
for E544A and R554A mutants were 12.2 and 22.3 nmol of
glutathionemgprotein1min1, respectively, resulting in a
nearly 8- and 6-fold decrease in transport efficiency of the
mutants. The decreased Vmax values obtained for the three
mutants,Q222A, E544A, andR554A,which could not be attrib-
uted to the decreased protein levels for the mutants, suggest
that these residues might play some critical role in the confor-
mation changes associated with translocation of the substrate
by the protein or, alternatively, in binding of protons to drive
the translocation of the substrate.
Among themutants that weremoderately affected in activity
(Group II, Table 2), T114A showed a drastic fall in its Vmax
value, which was in agreement with its decreased protein
expression a level. In contrast, mutants N137A, N357A, and
H445A showed a nearly 2-fold decrease in Km and corrected
Vmax values such that the transport efficiency for thesemutants
remained nearly similar to the wild type. Considering the
observed alterations in the kinetic parameters for these three
mutants, it appears likely that these residues are not directly
involved in interacting with the substrate. Instead, the intro-
duction of alanine at these positions most likely leads to minor
conformation changes in the transporter leading to decreased
protein stability and, hence, protein expression levels and indi-
rectly affects the substrate binding.
In contrast, the N124Amutant showed non-saturating bind-
ing even at 400 M glutathione concentration, making it diffi-
cult to obtain a reliable estimate of the kinetic parameters of the
mutant. Moreover, the initial rate of glutathione uptake at dif-
ferent concentrationwasmarginallymore than the background
values (measured in the vector transformed cells), implying a
significant defect in the substrate binding or translocation
mechanism of the protein for this particular mutant.
Functional Analysis of K562R and K562L Reveals the Lysine
Residue IsMandatory at Position 562 inHgt1p—The drastic fall
in activity of K562A, which otherwise exhibited total and sur-
face protein expression levels comparable with the wild-type
Hgt1p, suggested that this residuemight play an important role
in the transport activity of the protein. As the kinetic parame-
ters could not be measured for this mutant, we tried to further
probe the importance of this residue by construction and func-
tional evaluation of K562L and K562Rmutants. By substitution
of Lys-562 with a conservative residue (Arg) and a non-conser-
vative residue (Leu), we hoped to distinguish between the
requirement for positive charge and/or steric (side-chain vol-
ume) properties at the position 562 for the transport activity of
Hgt1p.
As shown in Fig. 5, replacement of Lys-562 either with posi-
tively charged Arg or iso-steric Leu led to drastic loss in the
protein activity. The K562L, like K562Amutant, failed to com-
plement the hgt1 defect of met15hgt1 strain (ABC 817)
even at as high as 200 M GSH and exhibited virtually no glu-
tathione uptake activity in the radiolabeled GSH assay (Fig. 5,A
and B). In contrast, K562R exhibited very poor complementa-
tion ability, with the mutated protein supporting growth of
met15hgt1 strain (ABC 817) at 50 M or higher glutathione
concentrations only, and no toxicity was observed (Fig. 5A).
The poor activity of the mutant was also reflected in the quan-
titative assay, where it recorded only 8–12%GSHuptake ability
relative to the wild-type protein at 100 M GSH (Fig. 5B).
Radiolabeled GSH uptake assay of K562R at higher GSH con-
centrations (400 M GSH) also failed to exhibit any significant
glutathione uptake into the cells (data not shown). An exami-
nation of the total protein expression levels (data not shown)
and cell surface expression levels (Fig. 5C) revealed that the
observed loss in activity of the mutants could not be attributed
to defective protein expression levels or trafficking.
Thus, the complete lack of activity of the K562A/L mutants
coupled with the inability of a positively charged residue (Arg)
to efficiently compensate for the lysine residue at position 562
suggests that presence of lysine per se is mandatory for the
functional activity of the transporter. Furthermore, the lack of
transport capability of K562R even at high GSH concentrations
implies that Lys-562 could be a key catalytic residue during the
substrate translocation process of the transporter.
Conservation Pattern of Residues Important for Hgt1p Func-
tion by Multiple Sequence Alignment with Other Oligopeptide
Transporters—Comparative sequence analysis can yield valua-
ble insights into the functional significance of a residue. Hence,
it was of interest to examine the status of the critical residues
found essential for the functional activity of Hgt1p in the other
peptide transport (PT) members, which have been character-
ized in terms of their substrate specificity.
The OPT family contains two distinct clades, the peptide
transporting (PT) clade and the yellow stripe (YS) clade that
are only remotely related to each other and are distinguished
on the basis of their substrate specificity and phylogenetic
analysis (3). The PT clade that contains 205 members,
including Hgt1p, has only four other members for which
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physiological substrate preference have been clearly estab-
lished. These include Pgt1, CaOpt1, Isp4, and AtOpt4. Pgt1
has been recently characterized as a high affinity glutathione
transporter from Schizosaccharomyces pombe (4), whereas
AtOpt4 from Arabidopsis thaliana, CaOpt1 from Candida
albicans, and Isp4 from S. pombe have been shown to specifi-
cally mediate uptake of oligopeptides (7, 35, 36).
Multiple sequence alignment of these five PT family mem-
bers revealed a number of polar/charged residues conserved
across the PT members within the predicted transmembrane
domains (Fig. 6). Interestingly, four of the six residues, Asn-124
(TMD1), Gln-222 (TMD4), and Glu-544 and Lys-562 (ICL
537–568) identified to be crucial for the substrate translocation
are completely conserved among the five PT members. The
high degree of conservation of Asn-124, Gln-222, Glu-544, and
Lys-562 among the evolutionary distant members of the PT
member suggests that these key residues could be important for
the catalytic activity of the PT clade transporters in general. In
contrast to the high degree of conservation of Gln-222 across
the PT members, Gln-526 in TMD9, the only residue which
exhibited a significant increase in Km for GSH without any sig-
nificant effect on Vmax was conserved only among the glutathi-
one transporters (Hgt1p and Pgt1).
Themutants R554A and E744A (TMD12), which exhibited a
significantly decreased transport activity, displayed a complete
conservation of positive and negative charge conservation at
the respective positions in the fiveOPTmembers (Fig. 6). In the
case of Glu-744, sequence alignment revealed that the gluta-
mate residue was found exclusively in Hgt1p and was not con-
served among the other members. Even the S. pombe glutathi-
one transporter lacked Glu-744 and contained an Asp at this
residue, like the other oligopeptide transporter members. As
the drastic loss in activity of E744Amutantwas attributed to the
entrapment of the mutant transporter in endoplasmic reticu-
lum, we investigated the residue further in the light of the
sequence analysis. We created an E744D mutation and evalu-
ated it for functionality. The E744D mutant, unlike E744A
mutant, exhibited functionality like the wild-type protein, as
seen from the plate assay, and exhibited around 65% transport
activity in the radiolabeled GSH assay (Fig. 5, A and B). The
E744D mutant was also able to traffic to the cell surface effi-
ciently, further underlining the requirement for a negative
charge at the amino acid position corresponding to 744 in
Hgt1p among the PT members.
FIGURE 5. Functional analysis of K562L, K562R, and E744D mutants
reveal significant loss in activity for K562L and K562R mutants. A, the
strain met15hgt1 (ABC 817) was transformed with plasmids bearing the
K562L, K562R, and E744D mutations in Hgt1p and used for plate-based dual
complementation-cum-toxicity assay by dilution spotting onminimal media
containing different concentrations of glutathione as described under
“Experimental Procedures.” B, measurement of the rate of radiolabeled glu-
tathione uptake. The data are represented as percentage of rate of uptake by
themutants relative to wild-type Hgt1p (WT). The rate of GSH uptake in wild-
type Hgt1p was 38.1  2.8 nmol min1mgprotein1. Experiments were
repeated twice, in triplicate, and representative data are shown as the
mean  S.D. C, cell surface localization analysis by indirect immunofluores-
cence using mouse anti-HA (Cell Signaling) primary antibody (at 1:100 dilu-
tion) and goat anti-mouse IgG horseradish peroxidase-conjugated antibody
(Cell Signaling) secondary antibody (at 1:500 dilution). Cells were visualized
using confocal microscope, as described under “Experimental Procedures.”
Only fluorescence images have been shown.
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DISCUSSION
The OPT transporter family catalyzes the uptake of oli-
gopeptides or peptide-like substrates such as metal-secondary
amino acid conjugates or glutathione in a proton-dependent
manner (3, 7). However, how the transport occurs, the TMD
helices, and the residues involved in either the recognition or
the translocation process are not known and have not been
investigated. A systematic effort was, therefore, initiated in this
study for the first time to obtain insights into this process in this
large, uncharacterized family of transporters.
Hgt1p, the high affinity glutathione transporter of S. cerevi-
siae, the best studied member of this family (1, 7, 8, 34, 37),
seemed ideally suited to yield
insights with a simple plate assay (9)
and the ready availability of gluta-
thione and radiolabeled glutathione
(in contrast to other substrates of
the OPT members). The substrate
ofHgt1p, glutathione, is hydrophilic
in nature, and therefore, charged
and polar residues within the trans-
membrane domains appeared to be
logical candidates for participating
in the substrate binding and trans-
location while also possibly playing
other structurally significant roles.
This assumption has been the basis
of our strategy for selecting a set of
22 polar and charged amino acids
across the predicted transmem-
brane domains in Hgt1p for alanine
mutagenesis in this study.
A detailed functional analysis of
these residues has revealed that
mutation of several of these residues
to the nonpolar residue alanine led
to a drastic reduction of activity.
Those showing a significant effect
were found in TMD1 (Thr-114,
Asn-124), TMD4 (Gln-222), and
TMD9 (Gln-526), implying these as
clearly very important domains for
the functional activity of Hgt1p. An
examination of the helix wheel
projection of these transmembrane
domains shows that whereas Thr-
114 andAsn-124 in TMD1 andGln-
526 in TMD9 clearly tend to cluster
with the other hydrophilic residues
in the domain, Gln-222 in TMD4
tends to lie just at the interface
between the polar and non-polar
faces of the transmembrane domain
(Fig. 7). Furthermore, Thr-114 and
Gln-222 are right in the center of
the helices, where as Asn-124 and
Gln-526 are much deeper, toward
the cytoplasmic end of the trans-
membrane domains (Fig. 7). Considering the strong affect of
these mutants on the kinetic parameters coupled to their posi-
tioning in the amphiphatic face of the helices, it appears likely
that these domains line the translocation channel of the trans-
porter. Among the remaining transmembrane domains tar-
geted in this study, one of the residues targeted in TMD2,
TMD6, and TMD7 showed a moderate defect, whereas a sec-
ond residue in this domain showed a mild or negligible loss in
functional activity. These domains might, thus, be peripherally
or indirectly involved in the transport process. In contrast,
although we targeted two residues in TMD3 and three residues
in TMD10 mutation to alanine, none of these mutations
FIGURE 6. Multiple sequence alignment for the protein sequences of the 5 PT members with defined
substrate specificity. Sequences of Hgt1 (gi 6322249 ), Pgt1 (gi 19115899 ), CaOpt1 (gi 2367386 ), Isp4
(gi 1827508 ), and AtOpt4 (gi 15237689 ) were retrieved from Entrez at the NCBI website and aligned using
ClustalX program (27). The sequence alignment has been edited to showonly the 12 putative transmembrane
domains in Hgt1 and the two putative transmembrane domains, excluded in the Becker’s group topology (33)
(shaded gray). The numbers corresponding to amino acids sequence of Hgt1 have been shown. The conserved
polar andcharged residuesare shadedyellow, and the residues conserved in theglutathione transporters (Hgt1
and Pgt1), although absent in non-glutathione transporters, are shaded cyan blue. The residues subjected to
alanine scanning in this study are marked with an arrow.
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showed a significant effect on activity, leaving these domains
open for further exploration for their role in forming the trans-
location channel.
Among the two intracellular regions 537–568 and 707–724
selected for mutational analysis in this study, only the domain
stretching the region 537–568 was found to be crucial for the
transporter activity. These two regions, although weakly pre-
dicted as putative transmembrane domains, have not been con-
sidered as TMDs in the final model because of their proline-
rich nature (33). However, three of the charged residues, Lys-562,
Glu-544, and Arg-554, belonging to the highly conserved pro-
line rich motif, 544EXIXGYX2PG(R/K)PXAX4KX2G565, in this
region were found to be critical for the translocation activity of
the protein (Table 3). Previously, experimental characteriza-
tion of the conserved proline residues in the transmembrane
domains of the voltage-gated potassium (Kv) channels and
ligand gated channels has revealed that these proline residues
provide a hinge or kink that is proposed to act as a molecular
switch to link the conformational changes in the protein with
the substrate translocation (38). Similarly, the conserved pro-
lines in the vicinity of the catalytic cysteines as PCX2–3P motif
in the transmembrane domain of DsbD, an integral membrane
oxidoreductase in E. coli, have been shown to be critical for the
functionally important conformational flexibility of the protein
(39). The results of the mutational analysis in our study and the
high degree of conservation of the region 537–568 in Hgt1p
(Fig. 6 and data not shown) seem to point toward an important
role of this proline-rich region in protein activity, and indeed,
we have recently observed that Pro-555 is important for trans-
port activity of Hgt1p.4 It is likely that the presence of the con-
served proline residues in the regionmight confer a high degree
of conformational flexibility to this region needed for substrate
translocation or enable the domain to partially transverse the
membrane, forming an inverted loop that could be critical for
substrate binding or translocation.
4 C. V. Srikanth and A. K. Bachhawat, unpublished data.
FIGURE 7. Residues Thr-114 and Asn-124 in TMD1, Gln-222 in TMD4, and Gln-526 in TMD9 critical for the transport activity of Hgt1p fall on the
hydrophilic faceof the respective transmembranedomains.Theupperpanelpresents thehelixwheelprojection, and the lowerpanelpresents the sideview
of thehelix (shown ingreen),with theextracellular side kepton the top. Thekey residues subjected toalaninemutagenesis in this studyare colored red,whereas
all the other polar residues in the TMDs are colored yellow. The side view of the TMDs was drawn using the PyMol Molecular viewer (Version 0.99). A, TMD1.
B, TMD4. C, TMD9.
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Of particular interest were the two glutamine residues, Gln-
222 in TMD4 and Gln-526 in TMD9. Although replacement of
the former with alanine resulted in a nearly 4-fold increase in
Km value and almost a complete loss in the catalytic turnover of
the transporter, Q526A mutant showed a nearly 8-fold
decrease in the Km values without a significant effect on Vmax.
Furthermore, Gln-222 was found conserved among different
OPT members, whereas Gln-526 was present only in Pgt1 but
not in the other functionally characterized oligopeptide trans-
porters. This differential pattern of conservation and effect
of mutations of Gln-222 and Gln-526 becomes particularly
remarkable as Pgt1, like Hgt1p, is the only other PT member
characterized to transport glutathione with high affinity,
whereas all the other three PTmembers, AtOpt4, CaOpt1, and
Isp4, have been shown to transport tetrapeptides and pen-
tapeptides but do not transport glutathione (4, 7, 35, 36). Taken
together, the results suggest that although both glutamine res-
idues participate in substrate transport, Gln-526 is critical in
identifying glutathione as substrate, whereas Gln-222 recog-
nizes a structural feature common to oligopeptides, including
glutathione, a modified tripeptide. In further considering the
dramatic effect of mutation on Gln-222 on Km and Vmax, it
could be that the residue might not be directly involved in sub-
strate binding butmight be needed for the translocation of sub-
strate and, hence, its influence on substrate binding as well. In
contrast Gln-526 appears to be strictly important for glutathi-
one binding/recognition.
Considering the role of Gln-526 as a key residue in identifi-
cation of glutathione as a substrate, it might be interesting to
probe the role of the other polar residues with limited conser-
vation only among the glutathione transporters (Fig. 6). Such
residues with limited conservation across the family have been
shown to be critical determinants of substrate selectivity among
the other transporters. For instance, among 18 homologues of
the sugar transporting family in S. cerevisiae, only the high
affinity galactose transporter (Gal2p) contains tyrosine as a
central aromatic acid in TMD10, whereas all the other 17
homologues, including Hxt2p, a high affinity glucose trans-
porter, contain phenylalanine at the corresponding site. Exper-
imental studies have shown that the presence of tyrosine in
Gal2p is crucial for differential recognition of galactose and
glucose between the two transporters (40, 41). Similarly, a sin-
gle difference of a glycine residue in TMD6 of GLYT1 for a
serine residue at the corresponding position in GLYT2 is suffi-
cient to explain the ability of GLYT1 to transport glycine and its
N-methyl derivative, sarcosine, whereas GLYT2 transports
only glycine (16).
Although Hgt1p and the S. pombe orthologue of the same
family, Pgt1, are the only two high affinity glutathione trans-
porters known (Km in the range of 45–65 M), low affinity
transporters of glutathione have been described and include the
MRP family of transporters (MRPs inmammals, Ycf1p in yeast)
that transport glutathione with low affinity (Km in the range of
10mM) and glutathione conjugates but belong to a very distinct
family, the ABC transporter superfamily (42). Interestingly,
mutational analysis of charged residues in MRP1 led to the
identification of key lysine residues that upon replacementwith
either Asp or Leu results in selective loss of transport of gluta-
thione or its conjugate cysteinyl leukotriene 4 (LTC4), with no
discernible effect on the transport of other organic acids or
methotrexate drug (17). This is particularly interesting when
one considers that even more direct evidence for a role of glu-
tamine and lysine residues in glutathione binding has also been
obtained from the crystal structure of a S. cerevisiae glutare-
doxin (Grx1) bound to glutathione (43), where it was observed
that a conserved glutamine and lysine residue are involved in
anchoring the glycine moiety of the substrate by a hydrogen-
bonding network. A similar role for a glutamine residue has
been identified in other glutaredoxins and glutathione S-trans-
ferases (44–46).
In conclusion, the findings described in this report have
enabled us to generate the first structural insights into the func-
tioning of a high affinity glutathione transporter, Hgt1p, laying
a platform for amore detailed investigation into the importance
of these residues and the TMDs 1, 4, and 9 in the transporter
activity of Hgt1p. Considering that members of the OPT family
have been implicated in metal and oligopeptide distribution
and development processes in plants and mating and survival
under adverse conditions in fungi, the insights gained with
Hgt1p could pave the way for future efforts to understand and
even manipulate the other OPT members.
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